Diabetes Clinical Trials in Atlanta

Showing 161-180 of 475 trials

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

NCT04020822

The purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with insulin requiring diabetes,18-75 years of age.

Type 1 DiabetesType 2 Diabetes

Medtronic Diabetes19 participantsStarted Jul 2019

Aurora, Colorado, United States • Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

ACR | LAB Urine Analysis Test System Evaluation of Performance

NCT04466501

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

DiabetesHypertension

Healthy.io Ltd.375 participantsStarted Jun 2019

Atlanta, Georgia, United States • Lexington, Kentucky, United States • Garden City, New York, United States

COMPLETEDPhase 4< 1 mile

Glargine U300 Hospital Trial

NCT03013985

The purpose of this study is to find out if treatment with Glargine U300 when compared to Glargine U100 will result in similar sugar control in patients with Type 2 Diabetes (T2D), who are admitted to the hospital and then transition at home, after discharge from the hospital.

Type 2 Diabetes

Emory University247 participantsStarted May 2017

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Minneapolis, Minnesota, United States +1 more locations

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

ACR | LAB Urine Analysis Test System Evaluation of Performance

Glargine U300 Hospital Trial

Diabetes Trials in Other Cities

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Day and Night Closed-loop in Young People With Type 1 Diabetes

Type 1 Diabetes and the Brain in Children

Rituximab in New Onset Type 1 Diabetes

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Atlanta